. 2020 Apr 24;9(4):e16799. doi: 10.2196/16799
©Marie-Eve Carrier, Linda Kwakkenbos, Warren R Nielson, Claire Fedoruk, Karen Nielsen, Katherine Milette, Janet Pope, Tracy Frech, Shadi Gholizadeh, Laura Hummers, Sindhu R Johnson, Pamela Piotrowski, Lisa Jewett, Jessica Gordon, Lorinda Chung, Dan Bilsker, Kimberly A Turner, Julie Cumin, Joep Welling, Catherine Fortune, Catarina Leite, Karen Gottesman, Maureen Sauve, Tatiana S Rodríguez-Reyna, Marie Hudson, Maggie Larche, Ward van Breda, Maria E Suarez-Almazor, Susan J Bartlett, Vanessa L. Malcarne, Maureen D. Mayes, Isabelle Boutron, Luc Mouthon, Fredrick Wigley, Brett D Thombs, SPIN Investigators. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 24.04.2020.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
Figure 1.
Scleroderma Patient-centered Intervention Network Cohort and feasibility trial flow diagram.